Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cutis. 1992 Nov;50(5):377-9.

Possible role of adjuvant therapy for thin malignant melanoma.

Author information

  • 1Department of Dermatology, University of Texas Medical Branch, Galveston 77555-0783.

Abstract

Patients with thin (less than 0.75 mm) malignant melanoma generally have an excellent prognosis following adequate surgical resection. However, some patients will experience recurrent disease. Once features for a high risk of recurrence in patients with malignant melanoma can be reliably identified, adjuvant intervention will be offered. Two formidable challenges remain before this strategy is adopted: we cannot yet accurately predict the subgroup of patients with thin malignant melanoma who will experience disease progression and an effective, nontoxic adjuvant regimen for this subgroup is not currently available. Future prospects for the adjuvant management of thin malignant melanoma are reviewed.

PMID:
1468260
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk